Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: Data from the EDITH study

Thrombosis Research

Volumn 119, Issue 4, 2007, Pages 433-439

  Oger, Emmanuel ^a,d   Lacut, Karine ^a,d   Mercier, Bernard ^c,d   Le Gal, Grégoire ^a,d   Leroyer, Christophe ^b,d   Pasquier, Elisabeth ^b,d   Férec, Claude ^c,d   Mottier, Dominique ^b,d  

^a Universite de Brest   (France)

^b Cavale Blanche Hospital   (France)

^c INSERM   (France)

^d BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FRANCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; UNIVERSITY HOSPITAL; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS;

EID: 33846447800     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.05.002     Document Type: Article

References (19)

1. Rosendaal F.R. Venous thrombosis: a multicausal disease. Lancet 353 (1999) 1167-1173
2. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 346 (1995) 1575-1582
3. Oger E., and Scarabin P.Y. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy. Drugs Aging 14 (1999) 55-61
4. Scarabin P.Y., and Oger E. Plu-Bureau. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 362 (2003) 428-432
5. Bjornstrom L., and Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19 (2005) 833-842
6. Straczek C., Alhenc-Gelas M., Aubry M.L., and Scarabin P.Y. Genetic variation at the estrogen receptor alpha locus in relation to venous thromboembolism risk among postmenopausal women. J Thromb Haemost 3 (2005) 1535-1537
7. Herrington D.M., Howard T.D., Hawkins G.A., Reboussin D.M., Xu J., Zheng S.L., et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346 (2002) 967-974
8. Straczek C., Alhenc-Gelas M., Aubry M.L., and Scarabin P.Y. Genetic variation at the estrogen receptor alpha locus in relation to venous thromboembolism risk among postmenopausal women. J Thromb Haemost 3 (2005) 1535-1537
9. Lussana, F., Faioni, E.M., Fontana, G., Brandi, M.L., Cattaneo, M. Association of estrogen receptor-alpha gene polymorphisms with deep vein thrombosis. J Thromb Haemost 2005; XXth Congress of the ISTH [abstract].
10. Shearman A.M., Cupples L.A., Demissie S., Peter I., Schmid C.H., Karas R.H., et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290 (2003) 2263-2270
11. Schuit S.C., Oei H.H., Witteman J.C., Geurts van Kessel C.H., van Meurs J.B., Nijhuis R.L., et al. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 291 (2004) 2969-2977
12. Herrington D.M., Howard T.D., Brosnihan K.B., McDonnell D.P., Li X., and Hawkins G.A. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 (2002) 1879-1882
13. van Meurs J.B., Schuit S.C., Weel A.E., van der K.M., Bergink A.P., Arp P.P., et al. Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 12 (2003) 1745-1754
14. Weel A.E., Uitterlinden A.G., Westendorp I.C., Burger H., Schuit S.C., Hofman A., et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84 (1999) 3146-3150
15. Weel A.E., Uitterlinden A.G., Westendorp I.C., Burger H., Schuit S.C., Hofman A., et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84 (1999) 3146-3150
16. Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160 (2000) 3415-3420
17. Grady D., Wenger N.K., Herrington D., Khan S., Furberg C., Hunninghake D., et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 132 (2000) 689-696
18. Douketis J.D., Julian J.A., Kearon C., Anderson D.R., Crowther M.A., and Bates S.M. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. J Thromb Haemost 3 (2005) 943-948
19. Simon T., Beau Yon de Jonage-Canonico M., Oger E., Wahl D., Conard J., Meyer G., et al., on behalf of the EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost 1 (2006) 71-76